The fate of Cursor and Replit and the rest could follow a number of paths. Cursor recently announced it is developing its own ...
Physics and Python stuff. Most of the videos here are either adapted from class lectures or solving physics problems. I ...
Physics and Python stuff. Most of the videos here are either adapted from class lectures or solving physics problems. I really like to use numerical calculations without all the fancy programming ...
Replimune Group’s REPL share price tumbled 54.2% over the past three months. The massive setback was observed after the FDA issued a complete response letter (CRL) in July, against the biologics ...
His snake eyes were bigger than his stomach. Florida might have a new ally in the ongoing fight against the invasive Burmese python scourge — chilly weather. Researchers who track the elusive and ...
On July 22, 2025, Replimune publicly announced that the U.S. Food and Drug Administration (FDA) had issued a "Complete Response Letter" (CRL) for its Biologics License Application (BLA) for RP1. This ...
If you are following Replimune Group (REPL) right now, you’re not alone. The company’s recent announcement about completing a Type A meeting with the FDA on its lead drug candidate, RP1, has put it ...
The threat actor behind the malware-as-a-service (MaaS) framework and loader called CastleLoader has also developed a remote access trojan known as CastleRAT. "Available in both Python and C variants, ...